enVVeno Medical Corporation
NVNO
$2.36
-$0.12-4.84%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -3.37% | 29.79% | 1.12% | -23.45% | -9.99% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.71% | 15.35% | -19.96% | -19.04% | -2.82% |
| Operating Income | -6.71% | -15.35% | 19.96% | 19.04% | 2.82% |
| Income Before Tax | -10.27% | -12.82% | 23.45% | 21.90% | 8.59% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -10.27% | -12.82% | 23.45% | 21.90% | 8.59% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.27% | -12.82% | 23.45% | 21.90% | 8.59% |
| EBIT | -6.71% | -15.35% | 19.96% | 19.04% | 2.82% |
| EBITDA | -7.01% | -15.76% | 20.06% | 19.21% | 2.86% |
| EPS Basic | 16.06% | 21.13% | 45.60% | 44.50% | 44.18% |
| Normalized Basic EPS | 20.09% | 19.92% | 43.56% | 42.69% | 40.74% |
| EPS Diluted | 16.06% | 21.13% | 45.60% | 44.50% | 44.18% |
| Normalized Diluted EPS | 20.09% | 19.92% | 43.56% | 42.69% | 40.74% |
| Average Basic Shares Outstanding | 31.38% | 43.06% | 40.73% | 40.73% | 63.76% |
| Average Diluted Shares Outstanding | 31.38% | 43.06% | 40.73% | 40.73% | 63.76% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
